What good are whizzy new drugs if the world can’t afford them?Bringing gene therapies and obesity drugs to the masses will require financial innovation too, says Steven PearsonIllustration: Dan WilliamsIN RECENT YEARS biotechnology and pharmaceutical science have produced quantum leaps that both offer great opportunity and pose great risk. Gene therapies for rare conditions and obesity drugs for larger segments of society could transform health for the better. But for that to happen, policymaker...